Artemis Therapeutics Inc Share Price OTC Bulletin Board
Equities
US04302Q1094
Biotechnology & Medical Research
Sales 2021 | 0.01 0.59 | Sales 2022 | 0.31 25.94 | Capitalization | 130M 10.84B |
---|---|---|---|---|---|
Net income 2021 | - 0 | Net income 2022 | -1M -83.41M | EV / Sales 2021 * | - |
Net cash position 2021 | 78.02K 6.51M | Net Debt 2022 | 301K 25.11M | EV / Sales 2022 | 41,88,43,518 x |
P/E ratio 2021 * |
-
| P/E ratio 2022 |
-48.8
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 12.93% |
Managers | Title | Age | Since |
---|---|---|---|
Shimon Citron
CEO | Chief Executive Officer | 70 | 30/22/30 |
David Dana
DFI | Director of Finance/CFO | 60 | 26/22/26 |
Dana Wolf
CTO | Chief Tech/Sci/R&D Officer | 66 | 02/16/02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Shimon Citron
CEO | Chief Executive Officer | 70 | 30/22/30 |
1st Jan change | Capi. | |
---|---|---|
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |